Tornquist K, Tashjian A H
Laboratory of Toxicology, Harvard School of Public Health, Boston, Massachusetts 02115.
Endocrinology. 1990 Apr;126(4):2068-78. doi: 10.1210/endo-126-4-2068.
In GH4C1 rat pituitary cells, 1,25-dihydroxycholecalciferol (1,25(OH)2D3) causes amplification of both the TRH-induced spike phase in cytosolic free calcium [( Ca2+]i) and the increase in [Ca2+]i induced by depolarization with K+. In the present study we investigated the actions of 12-O-tetradecanoyl-phorbol-13-acetate (TPA) on Ca2(+)-homeostasis in GH4C1 cells pretreated with 1,25(OH)2D3 for 24 h. In control and 1,25(OH)2D3-pretreated cells, incubation with TPA (0.1-300 nM) for 15 min in the presence of 45Ca2+ did not affect the basal uptake of 45Ca2+. However, if the cells were treated with 50 mM K+, TPA induced a time- and concentration-dependent decrease in depolarization-induced net 45Ca2+ uptake. A maximal decrease of 30-50% was observed with 100-300 nM TPA, 1,25(OH)2D3 pretreated cells being more responsive to the action of TPA than control cells. sn-1-Oleoyl-2-acetyl-glycerol, which mimics the action of TPA on protein kinase C (PKC), did not alter depolarization-induced uptake of 45Ca2+. Two agents which inhibit PKC activity, polymyxin B and K252A, did not prevent the effect of TPA on depolarization-induced uptake of 45Ca2+, whereas staurosporin totally inhibited the action of TPA. In Fura-2 loaded cells pretreated with 1,25(OH)2D3, incubation with 200 nM TPA for 9 min decreased the depolarization-induced spike and plateau phases of change in [Ca2+]i; only the spike phase was decreased in control cells. TPA did not affect basal [Ca2+]i in either group. Treatment with TPA for only 3 min decreased the TRH-induced spike in [Ca2+]i only in 1,25(OH)2D3 pretreated cells; however, after a 5-min treatment with TPA, the TRH-induced spike in [Ca2+]i was decreased in both control and 1,25(OH)2D3 pretreated cells. TPA did not affect the spike in [Ca2+] induced by 50 nM ionomycin. Na+/Ca2+ exchange was not altered by TPA, nor did TPA enhance efflux of 45Ca2+ from cells preloaded with 45Ca2+ for 2.5 h. We conclude that, in GH4C1 cells, TPA modulates plasma membrane calcium flux, probably via an inhibitory action on voltage-operated Ca2+ channels. This inhibitory action may be independent of activation of PKC, and 1,25(OH)2D3 pretreated cells are more responsive to the actions of TPA than are control cells. These results are consistent with our previous findings that 1,25(OH)2D3 enhances voltage-dependent Ca2+ channel activity in GH4C1 cells.
在GH4C1大鼠垂体细胞中,1,25 - 二羟基胆钙化醇(1,25(OH)2D3)可使促甲状腺激素释放激素(TRH)诱导的胞质游离钙([Ca2+]i)尖峰期以及K+去极化诱导的[Ca2+]i增加均增强。在本研究中,我们研究了12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA)对用1,25(OH)2D3预处理24小时的GH4C1细胞中Ca2+稳态的作用。在对照细胞和用1,25(OH)2D3预处理的细胞中,在45Ca2+存在的情况下用TPA(0.1 - 300 nM)孵育15分钟不影响45Ca2+的基础摄取。然而,如果细胞用50 mM K+处理,TPA会引起去极化诱导的净45Ca2+摄取呈时间和浓度依赖性降低。用100 - 300 nM TPA观察到最大降低30 - 50%,用1,25(OH)2D3预处理的细胞比对照细胞对TPA的作用更敏感。模拟TPA对蛋白激酶C(PKC)作用的sn - 1 - 油酰 - 2 - 乙酰甘油不会改变去极化诱导的45Ca2+摄取。两种抑制PKC活性的药物多粘菌素B和K252A不能阻止TPA对去极化诱导的45Ca2+摄取的作用,而星形孢菌素完全抑制TPA的作用。在用1,25(OH)2D3预处理的Fura - 2负载细胞中,用200 nM TPA孵育9分钟可降低去极化诱导的[Ca2+]i变化的尖峰期和平台期;在对照细胞中仅尖峰期降低。TPA在两组中均不影响基础[Ca2+]i。仅用TPA处理3分钟仅在1,25(OH)2D3预处理的细胞中降低TRH诱导的[Ca2+]i尖峰;然而,在用TPA处理5分钟后,对照细胞和用1,25(OH)2D3预处理的细胞中TRH诱导的[Ca2+]i尖峰均降低。TPA不影响50 nM离子霉素诱导的[Ca2+]尖峰。TPA不改变Na+/Ca2+交换,也不增强预先用45Ca2+加载2.5小时的细胞中45Ca2+的流出。我们得出结论,在GH4C1细胞中,TPA可能通过对电压门控Ca2+通道的抑制作用来调节质膜钙通量。这种抑制作用可能独立于PKC的激活,并且用1,25(OH)2D3预处理的细胞比对照细胞对TPA的作用更敏感。这些结果与我们之前发现的1,25(OH)2D3增强GH4C1细胞中电压依赖性Ca2+通道活性一致。